Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

THE SCRIPPS RESEARCH INSTITUTE

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1924-12-11

Employees: 1K

Market Cap: -

Website: https://powermom.scripps.edu

Clinical Trials

First-in-human Study of CCW702 in Patients With Metastatic Castration Resistant Prostate Cancer

Phase 1

Terminated

Conditions: Metastatic Castration-Resistant Prostate Adenocarcinoma

Interventions: Drug: CCW702

First Posted Date: 2019-09-04

Last Posted Date: 2023-05-12

Lead Sponsor: Calibr, a division of Scripps Research

Target Recruit Count: 22

Registration Number: NCT04077021

Locations: 🇺🇸
University of California at San Diego, San Diego, California, United States
🇺🇸
Johns Hopkins University - Sydney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, United States
🇺🇸
Karmanos Cancer Institute, Detroit, Michigan, United States

and more 2 locations

Medication Development in Alcoholism: Apremilast Versus Placebo

Phase 2

Completed

Conditions: Alcohol Use Disorder

Interventions: Drug: Apremilast
Drug: Placebo

First Posted Date: 2017-06-05

Last Posted Date: 2022-09-16

Lead Sponsor: The Scripps Research Institute

Target Recruit Count: 51

Registration Number: NCT03175549

Locations: 🇺🇸
The Scripps Research Institute Pearson Center for Alcoholism and Addiction Research, La Jolla, California, United States

A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of KA34 in Subjects With Knee Osteoarthritis

Phase 1

Completed

Conditions: Osteoarthritis, Knee

Interventions: Drug: Placebo
Drug: KA34

First Posted Date: 2017-04-28

Last Posted Date: 2022-12-27

Lead Sponsor: Calibr, a division of Scripps Research

Target Recruit Count: 60

Registration Number: NCT03133676

Locations: 🇺🇸
Diablo Clinical Research, Walnut Creek, California, United States
🇺🇸
Clinical Research of West Florida, Clearwater, Florida, United States
🇺🇸
Bioclinica Research, Orlando, Florida, United States

and more 1 locations

Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and Dependence

Phase 2

Completed

Conditions: Cannabis Dependence
Alcohol Dependence
Cannabis Use Disorder
Alcohol Use Disorder

Interventions: Drug: Placebo
Drug: aprepitant
Behavioral: Manual-guided behavioral counseling

First Posted Date: 2014-08-06

Last Posted Date: 2017-08-02

Lead Sponsor: The Scripps Research Institute

Target Recruit Count: 20

Registration Number: NCT02210195

Locations: 🇺🇸
The Scripps Research Institute, La Jolla, California, United States

Mifepristone Treatment of Alcohol Use Disorder

Phase 2

Completed

Conditions: Alcohol Abuse
Alcohol Use Disorders
Alcoholism
Alcohol Dependence

Interventions: Behavioral: Standardized behavioral therapy
Drug: Mifepristone 1200 mg daily
Drug: Placebo

First Posted Date: 2014-07-02

Last Posted Date: 2022-10-06

Lead Sponsor: The Scripps Research Institute

Target Recruit Count: 103

Registration Number: NCT02179749

Locations: 🇺🇸
The Scripps Research Institute, La Jolla, California, United States

Medication Development in Alcoholism: Investigating PPAR Agonists

Phase 2

Completed

Conditions: Alcoholism

Interventions: Drug: TRICOR (fenofibrate)
Drug: Sugar Pill

First Posted Date: 2014-06-06

Last Posted Date: 2017-06-02

Lead Sponsor: The Scripps Research Institute

Target Recruit Count: 50

Registration Number: NCT02158273

Locations: 🇺🇸
Susan Quello, La Jolla, California, United States

Treatment for Cannabis Withdrawal and Dependence

Phase 2

Completed

Conditions: Cannabis Dependence

Interventions: Drug: Placebo
Drug: Aprepitant
Behavioral: Manual-guided behavioral counseling

First Posted Date: 2012-06-05

Last Posted Date: 2017-05-01

Lead Sponsor: The Scripps Research Institute

Target Recruit Count: 70

Registration Number: NCT01611948

Locations: 🇺🇸
The Scripps Research Institute, La Jolla, California, United States

Medication Development in Alcoholism: Investigating Glucocorticoid Antagonists

Phase 2

Completed

Conditions: Alcoholism

Interventions: Drug: Sugar Pill
Drug: Korlym (mifepristone)

First Posted Date: 2012-03-08

Last Posted Date: 2016-06-24

Lead Sponsor: The Scripps Research Institute

Target Recruit Count: 56

Registration Number: NCT01548417

Locations: 🇺🇸
The Scripps Research Institute, La Jolla, California, United States

Gabapentin Treatment of Cannabis Dependence

Phase 2

Completed

Conditions: Cannabis Dependence
Cannabis Withdrawal
Cognitive Deficits

Interventions: Drug: gabapentin 1200mg/day
Drug: Placebo
Behavioral: Manual-guided behavioral counseling

First Posted Date: 2009-09-10

Last Posted Date: 2017-06-06

Lead Sponsor: The Scripps Research Institute

Target Recruit Count: 150

Registration Number: NCT00974376

Locations: 🇺🇸
The Scripps Research Institute, La Jolla, California, United States

Duloxetine Versus Pregabalin for Alcohol Dependence

Phase 2

Completed

Conditions: Alcohol Dependence

Interventions: Drug: Placebo
Drug: Duloxetine
Drug: Pregabalin
Behavioral: Standardized behavioral therapy

First Posted Date: 2009-06-29

Last Posted Date: 2017-05-04

Lead Sponsor: The Scripps Research Institute

Target Recruit Count: 150

Registration Number: NCT00929344

Locations: 🇺🇸
The Scripps Research Institute Pearson Center for Alcoholism and Addiction Research, La Jolla, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy